Company Data
NeuBase Therapeutics Inc.
Ticker
NBSE
Current Price
$0.378
Market Cap
$1.4M
Price Target
Refer to Report
Volume
171.0K
52wk Range
$0.36 - $3.16
Overview
NeuBase Therapeutics Inc is a pre-clinical stage biopharmaceutical company. It is engaged in the development of gene silencing therapies with its synthetic antisense oligonucleotides. Its Patrol platform is focused on the development of drugs for rare genetic diseases such as Huntington’s Disease, Myotonic Dystrophy and Familial Parkinson’s Disease among others.